RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
7.6M
Position Mix
No options reported
Reported Value
$1.6B
Portfolio Weight
69.89%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$2.2B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
7.6M
Position Mix
No options reported
Reported Value
$1.6B
Portfolio Weight
69.89%
PBLS
Common StockParabilis Medicines, Inc.
Reported Shares
4.7M
Position Mix
No options reported
Reported Value
$150.6M
Portfolio Weight
6.75%
RLAY
Common StockRelay Therapeutics, Inc.
Reported Shares
6.8M
Position Mix
No options reported
Reported Value
$122.3M
Portfolio Weight
5.48%
ORIC
Common StockOric Pharmaceuticals, Inc.
Reported Shares
7.2M
Position Mix
No options reported
Reported Value
$96.5M
Portfolio Weight
4.32%
TYRA
Common StockTyra Biosciences, Inc.
Reported Shares
3.4M
Position Mix
No options reported
Reported Value
$75.4M
Portfolio Weight
3.38%
ALMS
Common StockALUMIS INC.
Reported Shares
4.6M
Position Mix
No options reported
Reported Value
$33.6M
Portfolio Weight
1.51%
ATTO
Common StockAttovia Therapeutics, Inc.
Reported Shares
1.8M
Position Mix
No options reported
Reported Value
$31.5M
Portfolio Weight
1.41%
KYMR
Common StockKymera Therapeutics, Inc.
Reported Shares
278.9K
Position Mix
No options reported
Reported Value
$31.2M
Portfolio Weight
1.40%
ETRA
Common StockElectra Therapeutics, Inc.
Reported Shares
2.6M
Position Mix
No options reported
Reported Value
$29.7M
Portfolio Weight
1.33%
ZYME
Common StockZymeworks Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$29.5M
Portfolio Weight
1.32%
SLN
Depositary ReceiptSilence Therapeutics plc
Reported Shares
1.7M
Position Mix
No options reported
Reported Value
$18.5M
Portfolio Weight
0.83%
CTMX
Common StockCytomX Therapeutics, Inc.
Reported Shares
4.4M
Position Mix
No options reported
Reported Value
$12.1M
Portfolio Weight
0.54%
AVTX
Common StockAvalo Therapeutics, Inc.
Reported Shares
766K
Position Mix
No options reported
Reported Value
$11.7M
Portfolio Weight
0.53%
GLUE
Common StockMonte Rosa Therapeutics, Inc.
Reported Shares
761.2K
Position Mix
No options reported
Reported Value
$9.1M
Portfolio Weight
0.41%
BRVE
Common StockBraveheart Bio, Inc.
Reported Shares
416.7K
Position Mix
No options reported
Reported Value
$8.4M
Portfolio Weight
0.38%
CRVS
Common StockCorvus Pharmaceuticals, Inc.
Reported Shares
450K
Position Mix
No options reported
Reported Value
$5.2M
Portfolio Weight
0.23%
ENGN
Common StockenGene Therapeutics Inc.
Reported Shares
2.3M
Position Mix
No options reported
Reported Value
$4.6M
Portfolio Weight
0.21%
CNTX
Common StockContext Therapeutics Inc.
Reported Shares
7.4M
Position Mix
No options reported
Reported Value
$2.2M
Portfolio Weight
0.10%